v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents [note 5] $ 47,958 $ 20,929
Marketable securities [note 5] 139,345 15,475
Total current assets 188,294 39,889
Non-current assets:    
Other assets and restricted cash [note 5] 268 52
Right-of-use assets [note 9] 34 64
Other intangible assets 169  
License agreement [note 3 and note 4] 640 751
Goodwill 1,034 1,034
Total assets 190,439 41,790
Current liabilities:    
Accrued compensation 2,938 1,921
Current contingent consideration [note 4 and note 5] 1,372 1,557
Current portion of long-term obligations [note 9] 36 61
Current portion of convertible debt [note 5 and note 6] 7,454 3,704
Warrant liability 182,724  
Pre-funded warrant liability 655  
Total current liabilities 197,657 9,082
Non-current portion of convertible debt [note 5 and note 6] 7,458 11,185
Long-term obligations [note 9]   5
Total liabilities 205,115 20,272
Commitments and contingencies [note 9]
Stockholders' equity:    
Common stock, $0.001 par value, 150,000,000 shares authorized, 102,717,200 issued and outstanding at June 30, 2026 and 53,233,988 issued and outstanding at December 31, 2025 170 121
Additional paid-in capital 330,405 281,613
Accumulated deficit (345,163) (260,226)
Accumulated other comprehensive income (88) 10
Total stockholders' equity (14,676) 21,518
Total liabilities and stockholders' equity 190,439 41,790
Nonrelated Party [Member]    
Current assets:    
Prepaid expenses and other assets 805 3,292
Current liabilities:    
Accounts payable 606 859
Accrued liabilities other 1,083 598
Accrued clinical liabilities 587 368
Related Parties [Member]    
Current assets:    
Prepaid expenses and other assets 186 193
Current liabilities:    
Accounts payable 0 8
Accrued liabilities other 21 6
Accrued clinical liabilities 181  
Series A Convertible Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock, value
Series B Convertible Preferred Stock [Member]    
Stockholders' equity:    
Convertible preferred stock, value